Skip Nav Destination
1-12 of 12
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Administration of BPX-501 Cells Following Aβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias
Franco Locatelli, Annalisa Ruggeri, MD PhD, Pietro Merli, MD, Swati Naik, MBBS, Rajni Agarwal, MD, Victor Aquino, MD, David A. Jacobsohn, MD, Waseem Qasim, MD PhD, Eneida R. Nemecek, MD, Lakshmanan Krishnamurti, MD, Deepa Manwani, MD, Melissa Kuhn, PharmD, Neena Kapoor
Blood (2018) 132 (Supplement 1): 307.
Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia
Stephan A. Grupp, MD PhD, Shannon L. Maude, MD PhD, Susana Rives, MD PhD, Andre Baruchel, MD, Michael W. Boyer, MD, Henrique Bittencourt, MD PhD, Peter Bader, MD PhD, Jochen Büchner, MDPhD, Theodore W. Laetsch, MD, Heather Stefanski, MDPhD, Gary Douglas Myers, MD, Muna Qayed, MD MSc, Michael A. Pulsipher, MD, Barbara De Moerloose, MD PhD, Gregory A. Yanik, MD, Kara L. Davis, DO, Paul L. Martin, MD PhD, Eneida R. Nemecek, MD, Christina Peters, MD, Joerg Krueger, MD, Adriana Balduzzi, MD, Nicolas Boissel, MD PhD, Francoise Marie Mechinaud, MD FRACP, Mimi Leung, Lamis K. Eldjerou, MD, Lan Yi, PhD, Karen Thudium Mueller, PharmD,MSc, Eric Bleickardt, MD, Hidefumi Hiramatsu, MD, PhD
Blood (2018) 132 (Supplement 1): 895.
Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder
Susan Prockop, MD, Ai Li, PhD, Robert A Baiocchi, MD PhD, Nancy Bunin, MD, Kris Michael Mahadeo, MD, Eneida R. Nemecek, MD, Sarah Nikiforow, MD PhD, Ran Reshef, MD, Donald Edward Tsai, MD PhD, Willis H. Navarro, MD, Richard J. O'Reilly, MD
Blood (2017) 130 (Supplement 1): 4520.
Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Stephan A. Grupp, MD PhD, Theodore W Laetsch, MD, Jochen Buechner, MD PhD, Henrique Bittencourt, MD PhD, Shannon L Maude, MD PhD, Michael R. Verneris, MD, Gary D Myers, MD, Michael W Boyer, MD, Susana Rives, MD PhD, Barbara De Moerloose, MD, Eneida R. Nemecek, MD, Krysta Schlis, MD, Paul L. Martin, MD PhD, Muna Qayed, MD MSc, Peter Bader, MD, Hidefumi Hiramatsu, MD PhD, Francoise Mechinaud, MDFRACP, Gregory A Yanik, MD, Christina Peters, MD, Andrea Biondi, MD, Andre Baruchel, MD, Nicolas Boissel, MD PhD, Joerg Krueger, MD, Carl H June, MD, Kapildeb Sen, PhD, Yiyun Zhang, PhD, Karen E Thudium, PharmD, MS, Patricia A Wood, MD PhD, Tetiana Taran, MD, Michael A Pulsipher, MD
Blood (2016) 128 (22): 221.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial
Paul G. Richardson, MD, Marcie Riches, MD, Nancy A. Kernan, MD, Joel A. Brochstein, MD, Shin Mineishi, MD, Amanda M. Termuhlen, MD, Sally Arai, MD, Stephan A. Grupp, MD PhD, Eva C. Guinan, MD, Paul L. Martin, MD PhD, Gideon Steinbach, MD PhD, Amrita Krishnan, Eneida R. Nemecek, MD, Sergio A. Giralt, MD, Tulio E. Rodriguez, MD, Reggie Duerst, MD, John J. Doyle, MD FRCPC, Joseph H. Antin, MD, Angela R. Smith, MD MS, Leslie E. Lehmann, MD, Richard E. Champlin, MD, Alfred Gillio, MD, Rajinder Bajwa, MBBS, MD MRCP, Ralph B. D'Agostino, PhD, Joseph Massaro, PhD, Maja Miloslavsky, PhD, Robin L. Hume, MS, Massimo Iacobelli, MD, Bijan Nejadnik, MD, Alison L. Hannah, MD, Robert J. Soiffer, MD
Blood (2015) 126 (23): 737.
Results Of a Phase I Study Of Clofarabine and 2 Gy Total Body Irradiation (TBI) As a Non-Myeloablative Preparative Regimen For Hematopoietic Stem Cell Transplantation (HSCT) In High Risk Children With Hematologic Malignancies: A Multi-Center TACL Study
Sandeep Soni, MD, Hisham Abdel-Azim, MD, Elena Eckroth, CCRC, Jeanette van der Geissen, BA, CCRP, Meghann Pine McManus, DO, MPH, Eneida R. Nemecek, MD, Richard Sposto, PhD, Blythe Thompson, MD, Ann E Woolfrey, MD, Haydar A Frangoul, MD
Blood (2013) 122 (21): 3286.
Prospective Phase II Multicenter Study of Conditioning with Treosulfan, Fludarabine and Low-Dose (2 Gy) Total Body Irradiation Followed by Hematopoietic Cell Transplantation From Related or Unrelated Donors for Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Boglarka Gyurkocza, M.D., Jonathan Gutman, MD, Eneida R. Nemecek, MD, Eileen Sickle, RN, Merav Bar, MD, Joachim Baumgart, PhD, Colleen Delaney, MD, MSc, Barry Storer, PhD, Frederick R. Appelbaum, MD, H. Joachim Deeg, MD
Blood (2012) 120 (21): 963.
Significant and Rapid Improvement in Survival After Unrelated Donor (URD) Hematopoietic Cell Transplantation (HCT): Analysis of National Marrow Donor Program (NMDP) Facilitated Transplants From 2000 to 2009
Navneet S. Majhail, MD, MS, Pintip Chitphakdithai, PhD, Ying Shan, MS, Roberta King, MPH, Bernadette Anton, RN, Robyn Ashton, RN, MSN, Ruth Bakken, RN, Bette Braem, MSSW, Steven M. Devine, MD, Gregory A. Hale, MD, Robert J Hartzman, MD, Chatchada Karanes, MD, Ginna G Laport, MD, Rebecca Lewis, Esq, Eneida R. Nemecek, MD, Susan Rossmann, MD, PhD, Nawraz Shawir, MBBS, Edward L. Snyder, MD, Galen E. Switzer, PhD, Willis H. Navarro, MD, John P. Miller, MD, PhD, Dennis L Confer, MD, John E. Levine, M.D., M.S.
Blood (2012) 120 (21): 234.
A Regimen of Treosulfan and Fludarabine Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for High-Risk Hematologic Malignancies Is Associated with Low Treatment-Related Mortality
Eneida R. Nemecek, MD, Mohamed L. Sorror, MD, MS, Kristine C. Doney, MD, Bart Lee Scott, MD, Tibor J. Kovacsovics, MD, Richard Thomas Maziarz, MD, Ann E Woolfrey, MD, Jean Sanders, MD, Paul V. O’Donnell, Katherine Guthrie, PhD, H. Joachim Deeg, MD
Blood (2008) 112 (11): 2994.
Damian J. Green, MD, John M. Pagel, MD, PhD, Eneida R. Nemecek, MD, Anastasia Pantelias, MA, Yukang Lin, PhD, Aimee L. Kenoyer, Darrell R. Fisher, PhD, D.S. Wilbur, PhD, Donald K. Hamlin, Ajay K. Gopal, MD, Oliver W. Press, MD, PhD
Blood (2007) 110 (11): 2336.
Extracorporeal Adsorption Following Infusion of Radiolabeled Anti-CD20 Antibody Clears Unbound Radioimmunoconjugate from the Circulation and Reduces Radiation Exposure of Normal Organs in the Nonhuman Primate.
Damian J. Green, MD, Eneida R. Nemecek, MD, Nathan Hedin, BS, Anastasia Pantelias, MA, Yukang Lin, PhD, John M. Pagel, MD,PhD, Darrell R. Fisher, PhD, Don K. Hamlin, BS, D. Scott Wilbur, PhD, Ajay Gopal, MD, Rune Nilsson, PhD, Bengt E.B. Sandberg, PhD, Oliver W. Press, MD,PhD
Blood (2006) 108 (11): 2500.
A Myeloablative Regimen Incorporating Radiolabeled Anti-CD45 (BC8) Antibody Followed by Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Advanced Acute Myeloid Leukemia (AML).
Eneida R. Nemecek, MD, John M. Pagel, MD, Joseph G. Rajendran, MD, Darrell R. Fisher, PhD, Frederick R. Appelbaum, MD, Oliver W. Press, MD, PhD, Dana C. Matthews, MD
Blood (2004) 104 (11): 828.